The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review.

Montero‐Vilchez, Trinidad; Martínez-López, Antonio Manuel; Salvador-Rodriguez, Luis; Arias-Santiago, Salvador; Molina-Leyva, Alejandro

doi:10.1111/dth.13456

Record: found
Abstract: not found
Article: not found

The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review.

Author(s): Trinidad Montero-Vilchez ¹ , Antonio Martinez-Lopez ¹ ^, ² , Luis Salvador-Rodriguez ¹ , Salvador Arias-Santiago ¹ ^, ² ^, ³ , Alejandro Molina-Leyva ¹ ^, ² ^, ⁴

Publication date (Electronic): May 2020

Journal: Dermatologic therapy

Publisher: Wiley

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Dermatol Ther

Title: Dermatologic therapy

Publisher: Wiley

ISSN (Electronic): 1529-8019

ISSN (Print): 1396-0296

Publication date (Electronic): May 2020

Volume: 33

Issue: 3

Affiliations

[1 ] Hidradenitis Suppurativa Clinic, Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.

[2 ] Instituto de Investigación Biosanitaria IBS, Granada, Spain.

[3 ] Dermatology Department, University of Granada, Granada, Spain.

[4 ] European Hidradenitis Suppurativa Foundation (EHSF), Dessau-Roßlau, Germany.

Article

DOI: 10.1111/dth.13456

PubMed ID: 32319172

SO-VID: 2c6a2ab3-662d-40b2-a2a4-f5221a256964

History

Data availability:

Comments

Comment on this article

scite_

Cited by 16

See all cited by